Results 231 to 240 of about 353,961 (321)

Severe, Non‐apneic Respiratory Dysfunction and Hypoxia following Generalized Convulsive Seizures

open access: yesAnnals of Neurology, EarlyView.
Objective Sudden unexpected death in epilepsy (SUDEP) is a devastating consequence of some generalized convulsive seizures (GCS). Recent work has focused on seizure related apnea as a biomarker of SUDEP risk, frequently without characterizing the adequacy of non‐apneic ventilation or identifying other dysfunctional breathing patterns.
Haley E. Pysick   +9 more
wiley   +1 more source

Sleep and Alertness in Medical Interns and Residents: An Observational Study on the Role of Extended Shifts

open access: yesSleep, 2017
M. Basner   +9 more
semanticscholar   +1 more source

Cognitive performance and variability in dromedary camels: insights from a comparative psychometric approach. [PDF]

open access: yesBMC Vet Res
Iglesias Pastrana C   +4 more
europepmc   +1 more source

Performance Investigation of Eco‐Friendly Refrigerant Mixtures as an Alternative to R134a in Vapour‐Compression Refrigeration System

open access: yesAsia-Pacific Journal of Chemical Engineering, EarlyView.
ABSTRACT The growing impacts of climate change and energy scarcity demand environmentally sustainable refrigeration solutions. This study investigates eco‐friendly refrigerants (R152a, R290 and R600a) and their optimized ternary mixture as alternatives to R134a. Four blend compositions were analysed using experimental testing and REFPROP 10.0 modelling
M. Periyasamy, P. Senthilkumar
wiley   +1 more source

Cognitive impairment in chronic inflammatory demyelinating polyneuropathy. [PDF]

open access: yesJ Neurol
Steiner OL   +3 more
europepmc   +1 more source

Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell–Targeted Therapies

open access: yesArthritis &Rheumatology, EarlyView.
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley   +1 more source

Home - About - Disclaimer - Privacy